E-059 The prognostic significance of age in the adolescent and young adult population with stroke status post mechanical thrombectomy

Abstract

Conclusion A lower dose of ticagrelor (45 mg twice daily) appears to be a safe and effective in this small cohort of patients who are resistant to clopidogrel per P2Y 12 testing and who have increased risk of ischemic or hemorrhagic strokes due to neurovascular pathologies and implants. Further randomized studies are required to confirm these findings.